Ask AI
ProCE Banner Activity

Call to Action in Systemic Mastocytosis: Strategies to Advance Recognition and Timely Treatment Across Disciplines

Clinical Thought

Understand the latest advances in recognizing and managing patients with systemic mastocytosis (SM), including strategies for identifying SM in those who present with nonspecific or varied symptoms, addressing the challenge of delayed diagnosis, and supporting multidisciplinary evaluation.

Released: January 06, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Blueprint Medicines Corporation.

Blueprint Medicines Corporation

Target Audience

This activity is intended for US-based physicians, including residents and fellows, physician associates, nurse practitioners and other HCPs who care for patients with dermatological conditions.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Refer appropriate patients to specialists for multidisciplinary evaluation

Disclosure

Primary Author

Thanai Pongdee, MD: researcher: Blueprint Medicines, Sanofi, Telios; consultant/advisor/speaker: AstraZeneca, Cogent Biosciences, GSK.